Featured Articles

Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies

By August 17, 2020August 19th, 2024No Comments

Featured Article

Featured Article

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin secondary to inflammatory skin conditions, dermatologic therapies, and external stimuli. Because PIH is a common condition that has a substantial effect on the quality of life, an understanding of its treatment modalities is essential. Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies focus on PIH. This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers.

Read more

This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers.

Adele Shenoy BA, Raman Madan MD

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin, secondary to inflammatory skin conditions such as acne, atopic dermatitis, contact dermatitis, and psoriasis, as well as external factors such as burns and radiation therapy. An understanding of treatment strategies for PIH is essential, as it has a large impact on the quality of life.

Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies specifically address PIH. Thus, we conducted a literature review on PubMed using key words “post-inflammatory hyperpigmentation” OR “postinflammatory hyperpigmentation.”

Studies that did not specifically address PIH and articles that were not published in English were excluded. Additional studies were obtained by scanning references. This review adds to the current literature by discussing the evidence for topical therapies, chemical peels, and laser therapy used specifically for hyperpigmentation from PIH.

Read Full Article Now
Article Cited in this Post

Inclusive Derm Atlas PIH Images

You May Also Like

Journal of Drugs in Dermatology JDD featuring Botulinum Toxin in Facial Paralysis: A Neuroaesthetic Framework for Functional, Therapeutic, and Aesthetic Correction

Botulinum Toxin in Facial Paralysis: A Neuroaesthetic Framework for Functional, Therapeutic, and Aesthetic Correction

| Aesthetics, Featured Articles, Latest News | No Comments
Bridging Function and Aesthetics in Facial Paralysis Management  This is a must-read article from JDD that explores a transformative approach to neuromodulators in specialized patient care. Facial paralysis presents complex…
Journal of Drugs in Dermatology JDD featuring Treatment Adherence in Patients With Acne Vulgaris: A Narrative Review

Treatment Adherence in Patients With Acne Vulgaris: A Narrative Review

| Acne, Featured Articles, Latest News | No Comments
Unlocking the Adherence Puzzle in Acne Management  Have you read this latest insightful review from the Journal of Drugs in Dermatology (JDD)? Acne vulgaris remains one of the most frequent…
Journal of Drugs in Dermatology JDD featuring JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic Scars: A Multi-Center Retrospective Cohort Study

JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic Scars: A Multi-Center Retrospective Cohort Study

| Featured Articles, Latest News | No Comments
Targeting Fibroproliferative Disorders: Could JAK Inhibitors Lower Keloid and Hypertrophic Scar Risk?  Here is an essential new report from the JDD that could shift how we think about scar prevention.…

Leave a Reply